Marc F. Pelletier
Directeur Général chez GARDINER HEALTHCARE ACQUISITIONS CORP.
Postes actifs de Marc F. Pelletier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GARDINER HEALTHCARE ACQUISITIONS CORP. | Directeur Général | 01/03/2021 | - |
| Président | 01/03/2021 | - | |
| Investor Relations Contact | - | - | |
| Gardiner Founder LLC | Fondateur | 01/10/2020 | - |
| Corporate Officer/Principal | 01/10/2020 | - |
Historique de carrière de Marc F. Pelletier
Anciens postes connus de Marc F. Pelletier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Directeur Général | 01/01/2008 | 01/09/2020 |
| Directeur Technique/Scientifique/R&D | 01/01/2008 | - | |
| Fondateur | 01/01/2008 | 01/09/2020 | |
| President | - | 01/09/2020 | |
Iridia, Inc.
 Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA. | Directeur/Membre du Conseil | 01/01/2016 | 01/01/2019 |
| Fondateur | 01/01/2015 | 01/01/2019 | |
| Secrétaire Général | 01/01/2017 | 01/01/2019 |
Formation de Marc F. Pelletier
| McGill University | Doctorate Degree |
| Concordia University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 3 |
Opérationnelle
| Founder | 3 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Gardiner Healthcare Acquisitions Corp.
 Gardiner Healthcare Acquisitions Corp. Financial ConglomeratesFinance Gardiner Healthcare Acquisitions Corp. is a blank check company, which engages in merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination. The company was founded on March 25, 2021 and is headquartered in Shaker Heights, OH. | Finance |
| Gardiner Founder LLC | |
Iridia, Inc.
Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA. | Commercial Services |
- Bourse
- Insiders
- Marc F. Pelletier
- Expérience
